Women’s Health Outcomes in the U.S.: Spending More, Getting (Way) Less – 4 Charts from The Commonwealth Fund
Women in the U.S. have lower life expectancy, greater risks of heart disease, and more likely to face medical bills and self-rationing due to costs, we learn in the latest look into Health Care for Women: How the U.S. Compares Internationally from The Commonwealth Fund. The Fund identified four key conclusions in this global study: Mortality, shown in the first chart which illustrates women in the U.S. having the lowest life expectancy of 80 years versus women in other high-income countries; Health status, with women in the U.S. more likely to consume multiple prescription
Rebel Health: The Personal and Professional Passion of Susannah Fox
A “rebel” is both a noun and a verb. As a noun, Merriam-Webster tells us that a rebel is a person who opposes or takes up arms against a government or a ruler. As a verb, “to rebel” is to oppose or disobey one in authority or control, or otherwise renounce and resist by force the authority of one’s government.” An additional definition of the verb is, “to feel or exhibit anger or revulsion.” If you’ve been a patient facing a diagnosis of an illness, whether rare or common, you may well have felt these various feelings stirring inside your self.
An Extraordinary Life and Voice: A Call-to-Action from Casey Quinlan, featured in the Journal of Participatory Medicine
It is about time that a healthcare journal features examples of patient-leaders who have pioneered activism, innovation, and The first exemplar in this vein is Casey Quinlan, whom we lost all-too-soon earlier this year on 24th August. A team of her appreciative colleagues and friends wrote up the first in a new series called “Extraordinary Lives” published in the Journal of Participatory Medicine (JPM) titled “An Extraordinary Voice Expressed Through Humor: A Tribute to Casey Quinlan.” I played a minor role in getting this essay to the finish line, and am grateful to have had the opportunity to do so
Food-As-Medicine Grows Its Cred Across the Health/Care and Retail Ecosystem
In the nation’s search for spending smarter on health care, the U.S. could save at least $13 billion a year through deploying medically-tailored meals for people enrolled in Medicare, Medicaid, and private insurance programs, according to the True Cost of Food, research published by the Tufts School of Nutrition Science and Policy collaborating with The Rockefeller Foundation. It’s been one year since the White House convened the Conference on Hunger, Nutrition, and Health, kicking off the Biden Administration’s national strategy to improve health citizens’ access to healthy food as a matter of public health and economic security.
Large Employers Expect More Employees Will Experience Prolonged Health Impacts Due to COVID-19. and a Note About Telehealth Engagement
Due to their delayed return to medical services and diagnostic testing in the COVID-19 pandemic era, U.S. employees are expected to sustain serious health impacts that will drive employers’ health care costs, envisioned in the 2024 Large Employer Health Care Strategy Survey from the Business Group on Health (BGH). Dealing with mental health issues is the top health and well-being impact workers in large companies are addressing in 2023. Looking forward, large employers foresee their workers will be seeking care for chronic conditions and later-stage cancers that are diagnosed due to delayed screenings.
Consumers and Cancer: 3 Patient-Focused Charts From IQVIA on the State of the Oncology in 2023 – and Introducing CancerX
It’s time for the annual ASCO conference, currently convening the American Society for Clinical Oncology in Chicago. Starting 2nd June, there have been dozens of positive announcements updating research and therapies bringing hope to the 2 million new patients who will be diagnosed with cancer in the U.S. in 2023, and millions of more people worldwide. Just in time for #ASCO2023, the IQVIA Institute published their annual report on Global Oncology Trends 2023 – Outlook to 2027, an update featuring pipelines, therapy approvals, research updates, costs of oncology products, and patients.
Can Consumer Electronics Help Stem the Decline of U.S. Life-Years? A Preface for #CES2023
Life expectancy in the U.S. dropped nearly three years between 2019 and 2021, from close to 79 years down to 76. We ended 2022 with this new, sobering statistic from the Centers tor Disease Control (CDC). We begin 2023 with the opening of CES 2023, the world’s largest annual meet-up of consumer electronics innovators, companies, and retailers. How can digital health and other consumer-facing technologies help our health? First, consider the stark data point(s), and then we can better respond to the question’s answer in the Hot Points, below. In case you
How Will the “New” Health Economy Fare in a Macro-Economic Downturn?
What happens to a health care ecosystem when the volume of patients and revenues they generate decline? Add to that scenario a growing consensus for a likely recession in 2023. How would that further impact the micro-economy of health care? A report from Trilliant on the 2022 Trends Shaping the Health Economy helps to inform our response to that question. Start with Sanjula Jain’s bottom-line: that every health care stakeholder will be impacted by reduced yield. That’s the fewer patients, less revenue prediction, based on Trilliant’s 13 trends re-shaping the U.S. health
The More Chronic Conditions, the More Likely a Patient Will Have Medical Debt
There is a direct association between a person’s health status and patient outcomes and their financial health, quantified in original research published this week in JAMA Internal Medicine. Researchers from the University of Michigan (my alma mater) Medical School and Institute for Healthcare Policy and Innovation analyzed two years of commercial insurance claims data generated between January 2019 and January 2021, linking to commercial credit data from January 2021 for patients enrolled in a preferred providers organization in Michigan. The first chart illustrates the predicted probability of credit outcomes based on the
Gas ‘N Healthcare – How Transportation Links to Health Care Access and Financial Health
Some patients dealing with cancer at Mercy Health’s Lourdes Hospital have been supplied with gas cards. This gesture is enabling families to get to medical appointments around Paducah, Kentucky where, this week, car drivers faced regular gas priced at an average of $4.16 a gallon compared with $2.92 one year ago. Here’s the Hospital’s Facebook page featuring their gratitude to FiveStar Food Mart, the American Cancer Society, and the Mercy Health Foundation. “By providing cancer patients with gas cards, the cancer care team at Mercy Health Lourdes Hospital in Paducah hopes to mitigate financial challenges
Jasper, Scaling a Human Touch for People Dealing with Cancer, Now With Walgreens
Each year, the first Sunday in June marks National Cancer Survivors Day. This year’s NCSD occurred two days ago on Sunday, 5th June. When you’re a cancer survivor, or happen to love one, every day is time to be grateful and celebrate that survival of someone who has come through a cancer journey. We all know (or are) people who have survived cancer. We know that the recipe for battling cancer goes beyond chemotherapy. We know of the resilience and grit required in the process: body, mind, and spirit. “Celebrate Life” is the mantra of NCSD, as this year’s campaign
Patients Look Beyond the Pandemic to Pharma for Engagement, Innovation, and Integrity
The COVID-19 pandemic has impacted patients who were already deeply engaged with their own health care before the coronavirus emerged. Compared with a year ago, more patients and their advocates are seeking quality therapies, innovation, engagement, and integrity from pharmaceutical companies, based on research published today from PatientView. PatientView, based in the UK, has collaborated with over 40,000 patient advocacy organizations globally marking over 10 years doing this research. The eleventh annual report on the Corporate Reputation of Pharma was conducted among 2,150 patient groups between November 2021 and February 2022, covering health citizens in Europe (with 1,229 organizations), North
What Person-Centered Interoperability Looks Like: Seqster
He had me at the statement, “I believe health data is medicine.” Those were the words of Ardy Arianpour, CEO and Co-Founder of Seqster, when sharing with me how his company was founded. We met up last week at the DIA Europe 2022 meeting (Drug Information Association) in the cool SQUARE Conference Center in Brussels, Belgium (my current home base for work and life). It was a rare opportunity to sit still with this on-the-go guy with whom an hour spent is the equivalent of three hours with most other folks. Ardy and the team call Seqster “the operating system
The Financial Toxicity of Health Care Costs: From Cancer to FICO Scores
The financial toxicity of health care costs in the U.S. takes center stage in Health Populi this week as several events converge to highlight medical debt as a unique feature in American health care. “Medical debt is the most common collection tradeline reported on consumer credit records,” the Consumer Financial Protection Bureau called out in a report published March 1, 2022. CFPB published the report marking two years into the pandemic, discussing concerns about medical debt collections and reporting that grew during the COVID-19 crisis. Let’s connect the dots on: A joint announcement this week from three major credit agencies,
Medical Distancing Is Bad For Your Health
“Social distancing is great. Medical distancing? Not so much,” I observe in Medical Distancing in America: A Lingering Pandemic Side Effect., my essay published this week in Medecision’s Liberate Health blog. Since we learned to spell “coronavirus,” we also learned the meaning and risk-managing importance of physical distance early in the COVID-19 pandemic. But medical distancing became a corollary life-flow of the physical version, and for our collective health and well-being, it hasn’t been good for our health in ways beyond keeping our exposure to the virus at bay. For health care providers — physicians, hospitals, ambulatory clinics, diagnostic centers —
The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch
Getting totally rid of the coronavirus isn’t likely, so we humans must accept the fact that SARS-CoV-2 will be endemic. The economic and healthcare system impacts of this were explored in the Post-Covid Healthcare Landscape, delivered by Fitch Solutions’ Jamie Davies and Beau Noafshar, leaders in the Pharmaceuticals, Healthcare, and Medical Devices groups. I welcomed the opportunity to learn from this team’s approach in weaving together the dynamic issues that help us to plan for the long-tail of COVID-19 and its impact on the economy and prospects for the health care industry and health citizens. The first graph illustrates the
5.5 Million Years of Life Will Be Lost Due to COVID-19 in the U.S. in 2020
In 2020 in the U.S., 380,000 people are expected to die due to COVID-19. These people lost due to the coronavirus would, collectively, have lived another 5.5 million life-years would they not have succumbed to the virus. COVID-19 has cut lives short relative to their life expectancy, calculated in an analysis by the Pew Research Center based on CDC data from 2019 and 2020, coupled with additional statistics on life expectancy by age and gender. The bottom-line from the Pew Research Center’s analysis, simply stated, is that, “The pandemic…has killed many Americans who otherwise might have expected to live for
Post-Pandemic, U.S. Healthcare is Entering a “Provide More Care For Less” Era – Pondering PwC’s 2022 Forecast
In the COVID-19 pandemic, health care spending in the U.S. increased by a relatively low 6.0% in 2020. This year, medical cost trend will rise by 7.0%, expected to decline a bit in 2022 according to the annual study from PwC Health Research Institute, Medical Cost Trend: Behind the Numbers 2022. What’s “behind these numbers” are factors that will increase medical spending (the “inflators” in PwC speak) and the “deflators” that lower costs. Looking around the future corner, the inflators are expected to be: A COVID-19 “hangover,” leading to increased health care services utilization Preparations for the next pandemic, and
Ten Forces Shaping Health Care in 2021: A View from CVS Health
Expanding omni-channel, data-driven, cost-effective health care in the community, tailoring that care, and attending to mental health paint the picture of health through the lens of CVS Health. The company published the Health Trends Report 2021 today, calling out ten forces shaping health care this year. Those themes are, The Year of the Pharmacist The Next Step Forward in Cardiac Care Cancer Needs a Better Roadmap The EHR Hits Its Stride The Mental Health Shadow of COVID-19 Tailor Care to the Older Patient More Agents that Predict Disease Paying for the New Medical Miracle Virtual Care Goes Mainstream, and Diabetes
Call It Deferring Services or Self-Rationing, U.S. Consumers Are Still Avoiding Medical Care
Patients in the U.S. have been self-rationing medical care for many years, well before any of us knew what “PPE” meant or how to spell “coronavirus.” Nearly a decade ago, I cited the Kaiser Family Foundation Health Security Watch of May 2012 here in Health Populi. The first chart here shows that one in four U.S. adults had problems paying medical bills, largely delaying care due to cost for a visit or for prescription drugs. Fast-forward to 2020, a few months into the pandemic in the U.S.: PwC found consumers were delaying treatment for chronic conditions. In October 2020, The American Cancer
Will 2021 Be the Year of Sicker Americans? Pondering Late 2020 Data from IQVIA
Yesterday, IQVIA presented their end-of-year data based on medical claims in the U.S. health care system tracking the ups, downs, and ups of the coronavirus in America. IQVIA has been tracking COVID-19 medical trends globally from early 2020. The plotline of patient encounters for vaccines, prescribed medicines, foregone procedures and diagnostic visits to doctors begs the question: in 2021, will Americans be “sicker,” discovering later-stage cancer diagnoses, higher levels of pain due to delayed hip procedures, and eroded quality of life due to leaky guts? Here are a few snapshots that paint a picture for greater morbidity and potentially more “excess
U.S. Health Consumers’ Growing Financial Pressures, From COVID to Cancer
Before the coronavirus pandemic, patients had been transforming into health care payors, bearing high deductibles, greater out of pocket costs, and financial risk shifting to them for medical spending. In the wake of COVID-19, we see health consumers-as-payors impacted by the pandemic, as well as for existing diagnoses and chronic care management. There is weakening in U.S. consumers’ overall household finances, the latest report from the U.S. Bureau of Economic Analysis (BEA) asserted (published 25 November 2020). In John Leer’s look into the BEA report in Morning Consult, he wrote, “Decreases in income, the expiration of unemployment benefits and increased
West Virginia Was the Last State to ID a COVID-19 Positive Patient; The States’ Residents Are At Highest Risk for Severe Reaction to C19
Gallup has estimated 11 Million in U.S. at Severe Risk If Infected With COVID-19 in research published today. And the health citizens of West Virginia would be at greatest risk for having a severe reaction to the coronavirus. A “severe reaction” here means being critically ill or dying. The forecast doesn’t focus on the whole number of people in the US. who would be at-risk of contracting the coronavirus; the 11 million is the total number of Americans who have a “very high chance of becoming critically ill or dying” if 100% of the country were infected with C19. This
The State of the Union for Prescription Drug Prices
Tonight, President Trump will present his fourth annual State of the Union address. This morning we don’t have a transcript of the speech ahead of the event, but one topic remains high on U.S. voters’ priorities, across political party – prescription drug prices. Few issues unite U.S. voters in 2020 quite like supporting Medicare’s ability to negotiate drug prices with pharmaceutical companies, shown by the October 2019 Kaiser Family Foundation Health Tracking Poll. Whether Democrat, Independent, or Republican, most people living in America favor government intervention in regulating the cost of medicines in some way. In this poll, the top
Most Americans Regardless of Income Say It’s Unfair for Wealthier People to Get Better Health Care
In America, earning lower or middle incomes is a risk factor for having trouble accessing health care and/or paying for it. But most Americans, rich or not, believe that it’s unfair for wealthier people to get better health care, according to a January 2020 poll from NPR, the Robert Wood Johnson Foundation and Harvard Chan School of Public Health, Life Experiences and Income Equality in the United States. The survey was conducted in July and August 2019 among 1,885 U.S. adults 18 or older. Throughout the study, note the four annual household income categories gauged in the research: Top 1%
Longevity Stalls Around the World And Wealth, More Concentrated
Two separate and new OECD reports, updating health and the global economic outlook, raise two issues that are inter-related: that gains in longevity are stalling, with chronic illnesses and mental ill health affecting more people; and, as wealth grows more concentrated among the wealthy, the economic outlook around most of the world is also slowing. First, we’ll mine the Health at a Glance 2019 annual report covering data on population health, health system performance, and medical spending across OECD countries. The first chart arrays the x-y data points of life expectancy versus health spending for each of the OECD countries
Art As Medicine – WHO Weaves the Evidence for Arts’ Role in Improving Health
“What’s the evidence on the role of the arts in improving health and well-being?” asks a report from the World Health Organization‘s Europe region team (WHO-Europe). There’s a lot of proof supporting arts-as-medicine, WHO details in this paper, which synthesizes research published in over 3,000 studies. The first chart illustrates the logic model that bridges arts to health in three segments: “Components” of arts programs, including but not limited to cognitive stimulation (e.g., learning a new arts skill such as painting, drawing or journaling), social interaction (e.g., participating in theatre), physical activity (e.g., dance), and evocation of emotion (e.g., listening
Health Care Bills’ Financial Toxicity – Remembering the Jones’ of Whatcom County, WA
“In an extreme example of angst over expensive medical bills, an elderly Washington couple who lived near the U.S.-Canadian border died in a murder-suicide this week after leaving notes that detailed concerns about paying for medical care,” USA Today reported on August 10, 2019. Five years ago, financial toxicity as a side-effect was noted by two Sloan Kettering Medical Center in a landmark report on 60 Minutes in October 2014. Epidemiologist Peter Bach and oncologist Leonard Saltz told CBS’s Lesley Stahl, “A cancer diagnosis is one of the leading causes of personal bankruptcy…We need to take into account the financial
Intent, Insiders/Outsiders and Insights — Disney Institute’s Women’s Leadership Summit
There are many forms of magic inspired by Disney, the company. There’s the obvious attraction, the Magic Kingdom, that was Walt’s original destination vision, “imagineered” in 1932. Then there are other kinds of magic. The one I’m deep into in the moment is inspiration, ideation, and “reimagineering” my own thinking about work, legacy, and social justice. I’m grateful to have had the opportunity to spend much of this week at the inaugural Disney Institute Women’s Leadership Summit. The Institute convened about 300 women (and a handful of brave “He-for-She” men keen on diversity) in Orlando to learn about and brainstorm
How Consumers Look At Social Determinants of Health for Cancer, Diabetes and Mental Health
Enlightened health/care industry and public policy stakeholders have begun to embrace and address social determinants of health. These are the inputs that bolster health beyond health care services: they include economic stability like job security and income level (and equity), education, and access to healthy food, food security, safe neighborhoods, social support, clean environments (water and air), and in my own update on SDoH factors, access to broadband connectivity. As physician leaders in the AMA, technology advocates from AMIA, and numerous health plans focus efforts on strengthening social determinants, what do people – consumers, patients, caregivers — think about these
Doing Less Can Be Doing More for Healthcare – the Biggest Takeaway From ASCO 2018
Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes. Groundbreaking research presented at this week’s ASCO meeting found that some women diagnosed with certain forms of cancer do not benefit from undergoing chemotherapy. The American Society of Clinical Oncology (ASCO) is one of the largest medical meetings annually, and at this huge meeting these research results for the TAILORx trial were huge news with big
Personalized Medicine: Consumer Concerns About Coverage, Affordability and Privacy
Two in 3 Americans haven’t heard the phrases “personalized medicine” or “precision medicine.” When the concept of therapies tailored to individual patients is explained, most people like the idea of diagnostic tools that can identify biological markers and marry to personal medical records data to help determine medical treatments that best fit them. This picture of U.S. consumers’ views on personalized medicine comes from a survey conducted for PMC, the Personalized Medicine Coalition, and GenomeWeb, published in May 2018. The poll results are published in Public Perspectives on Personalized Medicine, with the top-line finding that life science industry innovators must
The US Covered Nearly 50% of Global Oncology Medicine Spending in 2017 – a market update from IQVIA
“We are at a remarkable point of cancer treatment,” noted Murray Aitken, Executive Director, IQVIA Institute for Human Data Science, in a call with media this week. 2017 was a banner year of innovative drug launches in oncology, Aitken coined, with more drugs used more extensively, driving improved patient for people dealing with cancer. This upbeat market description comes out of a report on Global Oncology Trends 2018 from the IQVIA Institute for Human Data Science. The subtitle of the report, “Innovation, Expansion and Disruption,” is appropriately put. The report covers these three themes across four sections: advances in therapies,
What A Duck Can Teach Us at CES 2018
We’re spending more time at CES 2018 calling out the societal and health impacts of technologies, especially for children and under-served people. How surprised and delighted I am to find a positive, enchanting impact at the convergence of kids and tech…from a duck. When I say “duck,” there are a few images that probably swim up in your mind’s eye: Donald, Daisy, Daffy, Howard, Darkwing, and the brand-famous Aflac Duck (who has his own Twitter handle @AflacDuck). It’s this last-named web-footed feathered friend who is a major star here at CES 2018 in the persona of My Special Aflac Duck.
U.S. Healthcare Spending & Outcomes in Five Charts: #EpicFail in the 2017 OECD Statistics
“Spend more. Get less.” If a retailer advertised using these four words, how many consumers would buy that product or service? This is the American reality of healthcare spending in 2016, told in the OECD report, Health at a Glance 2017. I present five charts from the study in this post, which together take the current snapshot health-economic lesson for the U.S. First, look at health expenditures as a share of gross domestic product: the U.S. is number one above Switzerland, France, and the UK, and about two times the OECD average. Note, too, the proportion of out-of-pocket and so-called
How We Live and Die in 2017: Obesity, Conflict and Mental Illness
Obesity, conflict, and mental illness contribute most to the ill health and mortality of the world’s population – especially in the U.S., according to the annual Global Burden of Disease study published this month in The Lancet and funded by The Bill & Melinda Gates Foundation. There’s good news and bad news in this research: on the upside, people are living longer. On the downside, there’s a lot of morbidity – that is, sub-optimal health – in those years. The study examines both YLLs (years of life lost) and YLDs (years lived with disability). “Death is a powerful motivator, both
The Pursuit of Health Equity and the State of U.S. Health Care
Between 2014 and 2015, death rates increased for eight of the ten leading causes; only death rates caused by cancer fell, and mortality rates for influenza and pneumonia stayed flat. The first chart paints this sobering portrait of Americans’ health outcomes, presented in the CDC’s data-rich 488-page primer, Health, United States, 2016. Think of this publication as America’s annual report on health. Every year, it is prepared and submitted to the President and Congress by the Secretary of the Department of Health and Human Services. This year’s report was delivered by DHHS Secretary Tom Price to President Trump and the
Pharma Industry Reputation Declines Second Year In A Row
U.S. consumers love technology, retail, and consumer products; automotive company reputations are improving, even with Volkswagen’s emission scandal potentially tarnishing the industry segment. The only corporate sector whose reputation fell in 2016 was the pharmaceutical industry’s, according to the Harris Poll’s 2017 Reputation Quotient report. The line chart illustrates the decline of pharma’s reputation, which puts it on par with its consumer perceptions in 2010 — just before Medicare Part D was legislated and implemented, which improved pharma’s image among American health citizens (especially older patients who tend to be more frequent consumers of prescription drugs). Pharma’s reputation quotient is back
Fighting Cancer with Hormel Vital Cuisine – Food as Medicine Update
Think “Hormel,” and you may have visions of SPAM, Chi-Chi’s salsa, Skippy peanut butter, and Dinty Moore corned beef hash. So what’s Hormel doing in the title of a Health Populi post, anyway, you might ask? Like many food companies, Hormel is broadening its product portfolio expanding with health. The company isn’t just moving to healthy eating for wellness’s sake, but boldly going where most food companies haven’t yet gone: developing products for people battling cancer. Vital Choices, a well-titled line of frozen meals, was developed by Hormel in collaboration with the American Cancer Society, Cancer Nutrition Consortium, the Culinary Institute
Color Me Well – Coloring Books As Rx for Wellness
Coloring books are best sellers in bookstores, craft merchandisers, newspaper stands, and on Amazon. Now, they’re joining the health and wellness world. The market growth of coloring books has been recognized in national media like the Washington Post, who called the phenomenon, “a bright spot in the financial results of publishers and retailers alike.” Nielsen Bookscan estimated that 12 million were sold in 2015, up from 1 million in 2014. Publishers Weekly covered the craze in November 2015. A Forbes column said, “The adult coloring craze continues and there is no end in sight.” Some of the mental health benefits
Financial Toxicity: The High Cost of Cancer Drugs in the U.S.
Two news items published in the past week point to the yin/yang of cancer survivorship and the high prices of cancer drugs. The good news: a record number of people in the US are surviving cancer, according to the American Cancer Society. That number is 15.5 million Americans, according to a study in the cancer journal CA. Note the demographics of cancer survivors: One-half are 70 years of age and older 56% were diagnosed in the past ten years, and one-third in the past 5 years Women were more likely to have had breast cancer (3.5 mm), uterine cancer (757,000),
Expect Double-Digit Rx Cost Growth to 2020 – Implications for Oncology
In the U.S., spending on prescription medicines reached $425 bn in 2015, a 12% increase over 2014. For context, that Rx spending comprised about 14% of the American healthcare spend (based on roughly $3 trillion reported in the National Health Expenditure Accounts in 2014). We can expect double-digit prescription drug cost growth over the next five years, according to forecasts in Medicines Use and Spending in the U.S. – A Review of 2015 and Outlook to 2020 from IMS Institute of Healthcare Informatics. The biggest cost growth driver is specialty medicines, which accounted for $151 bn of the total Rx spend
The Average Price of a New Specialty Drug Exceeds Median U.S. Annual Income; and a Tweet from Pam Anderson
The average price for a specialty drug was $53,384 in 2013; the average household income was $52,250. Thus, even allocating 100% of a family’s annual earnings to pay for a drug wouldn’t stretch far enough to cover it in 2013, nor would it do so today in 2015. This sober health economic artifact comes from the latest Rx Price Watch Report from the AARP, detailing cost trends for prescription drugs across all segments — generics, brands and specialty drugs. Contrast, as well, the $53K for the average specialty drug with the median 2013 Social Security benefit payout of $15,526 and median Medicare
Supersize Rx: the impact of specialty drug spending and Hep C in 2014
The number of people in the U.S. spending over $100,000 a year on prescription drugs tripled in 2014, according to Super Spending: U.S. Trends in High-Cost Medication Use, from The Express Scripts Lab. Express Scripts is a pharmacy benefits management company that manages over one billion prescriptions a year. The company analyzed prescription drug claims for 31.5 million health plan members for this study, in commercially insured, Medicare, and Medicaid plans. The big-dollar story in 2014 was Hepatitis C, with a relatively small patient population but a super-sized drug spend as the first chart shows: a very tall blue bar (Rx
In a world of digital health data, more sick people trade off privacy risks
People managing chronic diseases are more likely to have accessed information in their electronic medical records — and are also less likely to worry about the privacy risks of their personal electronic health information compared with people who are healthy. Over 2,000 people, both those who say they’re healthy and those with chronic conditions, were surveyed by Accenture in February-March 2014, and their responses are summarized in the report, Consumers with Chronic Conditions Believe the Ability to Access Electronic Medical Records Outweighs Concern of Privacy Invasion. Slight more consumers are concerned about privacy risks related to online banking, online shopping,
What CVS going tobacco-free means for health and business
Bravo! to CVS/pharmacy who today announced it would pull tobacco products from store shelves by October 2014. “The sale of tobacco products is inconsistent with our purpose,” the company’s press release asserts. The move will cost CVS $1.5 billion in revenue annually, as the company seeks to consolidate its position as a health company. CVS/pharmacy is part of CVS Caremark, which includes the retail pharmacy chain (the second-largest in the U.S.), a pharmacy benefit management company (Caremark), and retail health clinics (Minute Clinics). CVS Caremark also participates in a healthy communities program issuing grants for projects that focus on health
Schizo about smoking
There’s truly good news for public health about smoking: January 11th marked the 50th anniversary of the U.S. Surgeon General’s Report on Smoking and Health. That’s five decades’ worth of progress raising peoples’ awareness about the toxic impact of nicotine and chemicals embodied in cigarettes, and deleterious impacts on health and the economy. As a result, smoking rates have been cut in half since 1964, as the downward-sloping graph illustrates. With that happy news in my subconscious, I took a long walk, tracked by my digital device, through the Venetian Hotel in Las Vegas last week, bound for the 2014 Consumer Electronics
More chronically ill people use online health resources – but they’re not so social, Pew finds
People who are diagnosed with at least one chronic medical condition are more likely to seek information online, use social media to understand peer patients’ reviews on drugs and treatments, and learn from other patients about their personal health experiences. While that’s encouraging news for a health empowerment headline, the underlying challenge that should prevent congratulatory fist-bumps among patient-engagement proponents is that people living with chronic disease are less likely to have internet access. Why? Because chronically ill people tend to be older and less educated, and they’re also less likely to be working. Simply put, “People living with chronic
Color us stressed – how to deal
Coast-to-coast, stress is the modus vivendi for most Americans: 55% of people feel stressed in every day life, according to a study from Televox. A Stressful Nation: Americans Search for a Healthy Balance paints a picture of a nation of physically inactive people working too hard and playing too little. And far more women feel the stress than men do. 64% of people say they’re stressed during a typical workday. 52% of people see stress negatively impacting their lives. And nearly one-half of people believe they could better manage their stress. As a result, physicians say that Americans are experiencing negative
Make health care “feel” more like retail via transparency
Consumers who are well-covered by health insurance are in favor of talking about costs with their doctors. This research finding illustrates the fact that price transparency in health care isn’t just the concern of un- and under-insured people, but that shining the light on the price of health care is everybody’s business. But it’s also the case that most physicians aren’t yet involved in these health-financial conversations with their patients. Two studies presented at the recent 2013 annual meeting of the American Society of Clinical Oncology (ASCO) learned that patients are keen to know more about health care costs from
Mobile health apps – opportunity for patients and doctors to co-create the evidence
There are thousands of downloadable apps that people can use that touch on health. But among the 40,000+ mobile health apps available in iTunes, which most effectively drive health and efficient care? To answer that question, the IMS Institute for Healthcare Informatics analyzed 43,689 health, fitness and medical apps in the Apple iTunes store as of June 2013. These split into what IMS categorized as 23,682 “genuine” health care apps, and 20,007 falling into miscellaneous categories such as product-specific apps, fashion and beauty, fertility, veterinary, and apps with “gimmicks” (IMS’s word) with no obvious health benefit. Among the 23,682 so-called
Economics of obesity and heart disease: We, the People, can bend the curves
The “O” word drives health costs in America ever-upward. Without bending the obesity curve downward toward healthy BMIs, America won’t be able to bend that stubborn cost curve, either. The Economic Impacts of Obesity report from Alere Wellbeing accounts for the costs of chronic diseases and how high obesity rates play out in the forms of absenteeism, presenteeism, and direct health care costs to employers, workers and society-at-large. Among the 10 costliest physical health conditions, the top 3 are angina, hypertension and diabetes — all related to obesity and amenable to lifestyle behavior change. The top-line numbers set the context:
7 Women and 1 Man Talking About Life, Health and Sex – Health 2.0 keeping it real
Women and binge drinking…job and financial stress…sleeplessness…caregiving challenges…sex…these were the topics covered in Health 2.0 Conference’s session aptly called “The Unmentionables.” The panel on October 1, 2013, was a rich, sobering and authentic conversation among 7 women and 1 man who kept it very real on the main stage of this mega-meeting that convenes health technology developers, marketers, health providers, insurers, investors, patient advocates, and public sector representatives (who, sadly, had to depart for Washington, DC, much earlier than intended due to the government shutdown). The Unmentionables is the brainchild of Alexandra Drane and her brilliant team at the Eliza
People not up-close-and-personal about personalized medicine…yet
Only 1 in 4 U.S. adults over 30 know what “personalized medicine” (PM) really is, and only 8% of people feel very knowledgeable about the concept based on Consumer Perspectives on Personalized Medicine from GfK, published online in August 2013. GfK surveyed 602 online adults 30 years and over between February and March 2013 drawn from the company’s KnowledgePanel sample of U.S. adults. Only 4% of people who have heard of personalized medicine describe it accurately as “medicine based on genome/genetic make up.” About one-half of people (52%) defined PM as medical care, treatment, or medicine geared toward individual needs. The poll
Losing your eyebrows, finding health and beauty
My friend Rachel leads education at Sephora in the King of Prussia Mall in suburban Philadelphia, PA. I’ve come to consider Rachel as my personal guress on all matters related to skin care. She’s a trusted member of my personal health ecosystem. I met with Rachel last week to consult on what lipsticks contain SPFs that could prevent my lips from burning in the sun for my vacation week on Lakes George and Placid. She informed me that very few cosmetic lip products have sufficient sun protection ingredients to protect my lips-on-the-Lakes. We accomplished our consult for my very small
Angelina and Abercrombie: connecting the dots for healthy body image
This has been a week of shocking contrasts for women’s body image: from the triumphant, empowering public health role model of Angelina Jolie, whose op-ed column, My Medical Choice, appeared in the New York Times on May 14th, to the marketing message snafu of Abercrombie & Fitch. First, the Abercrombie affair: Mike Jeffries, CEO, said the following in a 2006 Salon interview that virally surfaced: “Because good-looking people attract other good-looking people, and we want to market to cool, good-looking people. We don’t market to anyone other than that,” identifying the “cool kids” as the company’s target market. “A lot of
The decline and fall of pharmaceutical spending…short- or long-term phenomenon?
The prescription drug cost curve is bending…for the time being. Spending on medicines fell by 3.5% in 2012 and will continue to fall below overall health spending over the next five years to 2017. But different from general health spending, there’s a new game in town called specialty medicines, and they cost a whole lot more than the generics and the aging brands that bent the cost curve in 2012. The declining Rx spending story is only part of a complicated tale told in great detail in a comprehensive report from the IMS Institute for Healthcare Informatics, Declining Medicine Use
Let patients help: the BMJ covers an American ePatient’s learnings
In this week’s BMJ (British Medical Journal), an American patient tells his story about being equipped, enabled, empowered and engaged — the many “e’s” making up the prefix of “ePatient.” This definition comes out of the work of Dr. Tom Ferguson, who worked with the e-Patient Scholars Working Group in 2007, to publish the first white paper about the phenomenon, e-Patients: how they can help us heal health care. ePatient Dave is the patient-author of the BMJ piece, making the case for shared decision-making and patient involvement in health care decisions. He writes in the conclusion, “The value delivered by skilled
We are all health deputies in the #digitalhealth era: live from the 2013 Consumer Electronic Show
Reed Tuckson of UnitedHealthGroup was the first panelist to speak at the kickoff of the Digital Health Summit, the fastest-growing aspct of the 2013 Consumer Electronics Show (#2013CES). Tuckson implored the spillover audience to all, “self-deputize as national service agents in health,” recognizing that technology developers in the room at this show that’s focused on developers building Shiny New Digital Things have much to bring to health. As Andrew Thompson of Proteus Medical (the “invisible pill” company) said, “we can’t bend the health care cost curve; we have to break it.” This pioneering panel was all about offering new-new technologies
Wired health: living by numbers – a review of the event
Wired magazine, longtime evangelist for all-things-tech, has played a growing role in serving up health-tech content over the past several years, especially through the work of Thomas Goetz. This month, Wired featured an informative section on living by numbers — the theme of a new Wired conference held 15-16 October 2012 in New York City. This feels like the week of digital health on the east coast of the U.S.: several major meetings have convened that highlight the role of technology — especially, the Internet, mobile platforms, and Big Data — on health. Among the meetings were the NYeC Digital Health conference, Digital
Wellness and the global health citizen – carrying our own doctors, inside
Every patient carries her or his doctor inside, said the great Renaissance man, Albert Schweitzer. Based on Euro RSCG Worldwide’s Prosumer Report – My Body, Myself, Our Problem: Health and Wellness in Modern Times, health citizens globally have begun to take on Dr. Schweitzer’s vision. Clement Boisseau of Euro RSCG points out that people, globally, are fairly schizophrenic when it comes to thinking about empowerment over illness: check out the chart for perceptions by condition and disease state. Boisseau says that people perceive health today both in modern terms (such as feeling empowered to control some conditions), and archaic or “magically
Phonecare works – remote health via phones for people with cancer
People with cancer can successfully manage their pain and depression through telephone contact with health providers and home monitoring, demonstrated by a clinical trial conducted among 405 patients in Indiana. The randomized trial findings are published in the July 14, 2010, issue of JAMA in, Effect of Telecare Management on Pain and Depression in Patients With Cancer. In the study, the Indiana Cancer Pain and Depression (INCPAD) trial assessed patients with pain, depression, and both depression and pain. Pain and depression are the most common physical and psychological symptoms in cancer patients, according to an AHRQ Evidence Report/Technology Assessment. These symptoms go largely untreated
Flipping cancer the bird: can pop culture cure cancer?
70,000 young Americans between 15 and 39 years of age are diagnosed with cancer every year. This population falls in a gap between pediatric and adult cancer. Newly-diagnosed young adults often find themselves in a no-patients’-land, confronting a lack of targeted clinical trials and knowledgeable clinicians in local health markets.The National Cancer Institute says that survival rates for this group of cancer patients haven’t improved in over 30 years.That’s definitely cause to flip cancer the bird, and that’s exactly what the young actor, Zac Efron, has done.Efron is photographed with a young cancer patient, Emily Hobson, to focus on Stupid
The cost of cancer: can you spell "u-n-d-e-r–i-n-s-u-r-a-n-c-e?"
Published a few months before her death, It’s Always Something is the autobiography from the great Gilda Radner, who died of ovarian cancer 20 years ago at the age of 42. In the case of cancer, that “something” is all-too-often the case of under-insurance to cover treatment. High out-of-pocket costs for treatment, coupled with insurance premium payments, can force cancer patients to incur big debt or, ultimately, forgo treatment. Spending to Survive is a comprehensive and detailed report from Kaiser Family Foundation (KFF) and the American Cancer Society (ACS). The report’s subtitle, “cancer patients confront holes in the health
Purchasing Pink
Pink is all around. It’s October 1st. The annual proliferation of pink products promoting breast cancer awareness pervades purchasers’ prospective pickings. This year, there are lots of cosmetics to choose from, along with a Filofax, a vacuum cleaner, kitchen appliances, an iPod and various accessories to dress it up, foods, a Swiss army knife, and a set of pink knitting needles. Prevention Magazine online has several suggestions for “Beauty that Gives Back,” cosmetic companies offering products with some percentage of proceeds going to a variety of breast cancer charities. For example, La Mer Skin Creme can be purchased for
I was invited to be a Judge for the upcoming CES 2025 Innovation Awards in the category of digital health and connected fitness. So grateful to be part of this annual effort to identify the best in consumer-facing health solutions for self-care, condition management, and family well-being. Thank you, CTA!
Thank you Team Roche for inviting me to brainstorm patients as health citizens, consumers, payers, and voters in the Healthcare Transformers series.
For the past 15 years, the annual CES conference in Las Vegas has been my go-to meeting for updating my research and network in digital health and consumer-facing electronics that people find meaningful for their well-being, families, and home lives. I'll be back in Vegas in January for a full week of Media Days, one-on-one meetings, and speaking about my perspectives on health consumers.